Continuing Education Opportunities Highlight Asembia Specialty Pharmacy Summit

The annual 2017 Asembia Specialty Pharmacy Summit is steadily approaching. This year, Asembia estimates more than 5000 participants will be in attendance at the conference, which runs from April 30 to May 3, 2017, at Wynn and Encore in Las Vegas.

Attendees will not only have the opportunity to hear from experts across the specialty pharmacy landscape, they will also have the opportunity to receive continuing education (CE) credits. Pharmacy Times Continuing Education^TM is offering a robust series of CE opportunities throughout the conference.

The lineup will be highlighted by Specialty Pharmacy Times Editor-in-Chief, Dan Steiber, RPh, who will be speaking May 1, 2017, regarding standards in specialty pharmacy data and the role the industry plays in the health care space.

Below is an overview of 11 CE sessions to attend at Asembia this year:

Symposia Details

1. Understanding the Clinical and Economic Data of Botulinum Toxin in Chronic Migraine

This activity is supported by an educational grant from Allergan.

· April 30, 3 pm — 4:30 pm

2. Supporting Specialty Pharmacists in Improving Care for Patients with Psoriasis and Psoriatic Arthritis

This activity is supported by educational grants from Lilly and Celgene.

· May 1, 6:30 am — 8 am

3. Managing the CF Patient: Specialty Pharmacist’s Opportunity to Improve Outcomes

This activity is supported by an educational grant from Vertex.

· May 1, 3:30 pm — 5 pm

4. Standards in Specialty Pharmacy Data: The Time is Now

· May 1, 5 pm — 6:30 pm

· Location - Latour Ballroom, Wynn

· Speaker — Dan Steiber

· Description - Outline the role the role that specialty pharmacy plays in the health care space, as well as the need for pharmacy data standardization that has come about as a result of multiple prescription processing platforms and their interactions with payers though online adjudication. Understand the points of differentiation in specialty data versus other pharmacy providers.

5. Emerging Strategies in Rheumatoid Arthritis: A Focus on Reduction of Disease Progression and Disability

This activity is supported by an educational grant from Lilly.

· May 2, 6:30 am — 8 am

6. Specialty Pharmacy Updates in Managing Severe Asthma

This activity is supported by an educational grant from Novartis.

· May 2, 8:30 am — 10 am

7. Preventing Vision Loss in Diabetic Macular Edema—Role of Specialty Pharmacists

This activity is supported by an educational grant from Genentech.

· May 2, 10:30 am — 12 pm

8. Beyond the Conventional: Current and Emerging Therapies for Inflammatory Bowel Disease

This activity is supported by an educational grant from Takeda.

· May 2, 5 pm — 6:30 pm

9. Managing Idiopathic Pulmonary Fibrosis (IPF): Updates to Clinical Practice Guidelines and the Utility of New Treatments

This activity is supported by an educational grant from Genentech.

· May 3, 8:30 am — 10 am

10. Advances in the Treatment of Moderate to Severe Atopic Dermatitis: Practice Management Essentials for Specialty Pharmacists

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron.

· May 3, 10:30 am — 12 pm

11. RCE0197 - Improving the Impact of Specialty Pharmacists in Hemophilia Management

This activity is supported by an educational grant from CSL Behring.

· May 3, 4 pm — 5:30 pm